MY183588A
(en )
2021-02-27
New salvianolic acid compound l, preparation method and use thereof
NZ589445A
(en )
2013-06-28
Rasagiline for parkinson's disease modification
WO2010088000A3
(en )
2011-04-07
Antifibrotic compounds and uses thereof
TN2012000152A1
(en )
2013-12-12
Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
WO2011127333A3
(en )
2012-02-02
Compounds for treating disease, for administering, and for pharmaceutical compositions
WO2011014255A8
(en )
2012-03-15
Treatment of crohn's disease with laquinimod
NZ593199A
(en )
2012-11-30
Milnacipran for the long-term treatment of fybromyalgia syndrome
WO2012082718A3
(en )
2012-10-26
3-methanesulfonylpropionitrile for treating inflammation and pain
MX2011009709A
(es )
2011-12-06
Compuestos para el tratamiento de la inflamacion y del dolor.
NZ595767A
(en )
2012-12-21
Composition for the treatment of prostate cancer
TN2012000248A1
(en )
2013-12-12
Novel spiropiperidine compounds
UA97348C2
(en )
2012-02-10
HETEROCYCLIC NF-kB INHIBITORS
WO2013028818A8
(en )
2013-09-19
Pyrimido- pyridazinone compounds and use thereof
MX2012007590A
(es )
2012-07-30
Composicion para mejorar la funcion cerebral y metodo para mejorar la funcion cerebral.
SI1594885T1
(sl )
2009-06-30
Zdravilo za inhibiranje rasti tumorjev
TN2014000031A1
(en )
2015-07-01
Use of organic compound for the treatment of noonan syndrome
SG141358A1
(en )
2008-04-28
Treatment of psychiatric patients with reduced heptaic function with paliperidone
SG10201809506TA
(en )
2018-11-29
Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
MX2012006287A
(es )
2012-07-03
Activadores de azaindol glucocinasa.
NZ587941A
(en )
2012-11-30
Methods to inhibit tumor cell growth by using lansoprazole
UA42947U
(ru )
2009-07-27
Способ экспериментальной коррекции травматических повреждений роговицы
UA33293U
(ru )
2008-06-10
Способ лечения хронического эндометрита
MX2014000870A
(es )
2014-06-23
Composiciones farmaceuticas que comprenden 4-bromo-n-(imidazolidin -2-iliden)-1h-benzimidazol-5-amina para tratar enfermedades de la retina.
WO2011026193A8
(en )
2012-02-23
Cytotoxic compounds
UA48009U
(ru )
2010-02-25
Способ лечения пациентов с дисфункцией сфинктера одди